SEARCH

SEARCH BY CITATION

References

  • Accatino L., Pizarro M., Solis N. and Koenig C. S. (1998) Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat. Hepatology 28, 129140.
  • Albers D. S. and Sonsalla P. K. (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275, 11041114.
  • Ali S. F., Newport G. D., Holson R. R., Slikker W. Jr and Bowyer J. F. (1994) Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658, 3338.
  • Asanuma M. and Cadet J. L. (1998) Methamphetamine-induced increase in striatal NF-kappaB DNA-binding activity is attenuated in superoxide dismutase transgenic mice. Brain Res. Mol. Brain Res. 60, 305309.
  • Beal M. F. (2000) Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. 23, 298304.
  • Bell J. E. (1998) The neuropathology of adult HIV infection. Rev. Neurol. (Paris) 154, 816829.
  • Benzi G., Curti D., Pastoris O., Marzatico F., Villa R. F. and Dagani F. (1991) Sequential damage in mitochondrial complexes by peroxidative stress. Neurochem. Res. 16, 12951302.
  • Berger J. R. and Nath A. (1997) HIV dementia and the basal ganglia. Intervirology 40, 122131.
  • Berger J. R., Kumar M., Kumar A., Fernandez J. B. and Levin B. (1994) Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 8, 6771.
  • Berman S. B., Zigmond M. J. and Hastings T. G. (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67, 593600.
  • Boja J. W., Carroll F. I., Vaughan R. A., Kopajtic T. and Kuhar M. J. (1998) Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex. Synapse 30, 917.
  • Bowyer J. F., Tank A. W., Newport G. D., Slikker W. Jr, Ali S. F. and Holson R. R. (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260, 817824.
  • Bruce A. J., Malfroy B. and Baudry M. (1996) Beta-amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl Acad. Sci. USA 93, 23122316.
  • Brunswick D. J., Benmansour S., Tejani-Butt S. M. and Hauptmann M. (1992) Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse 11, 287293.
  • Cass W. A. and Manning M. W. (1999) Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. J. Neurosci. 19, 76537660.
  • Chen P., Mayne M., Power C. and Nath A. (1997) The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J. Biol. Chem. 272, 2238522388.
  • Cubells J. F., Rayport S., Rajendran G. and Sulzer D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14, 22602271.
  • Dykens J. A. (1994) Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca2+ and Na+: implications for neurodegeneration. J. Neurochem. 63, 584591.
  • Dykens J. A. (1997) Mitochondrial free radical production and oxidative pathophysiology: implications for neurodegenerative diseases , in Mitochondria and Free Radicals in Neurodegenerative Diseases (BealM. F., HowellN., Bodis-WollnerI., eds), pp. 5789. Wiley–Liss, New York.
  • Gavriil E. S., Cooney R. and Weeks B. S. (2000) Tat mediates apoptosis in vivo in the rat central nervous system. Biochem. Biophys. Res. Commun. 267, 252256.
  • Gibb J. W. and Kogan F. J. (1979) Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch. Pharmacol. 310, 185187.
  • Gluck M. R., Moy L. Y., Jayatilleke E., Hogan K. A., Manzino L. and Sonsalla P. K. (2001) Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J. Neurochem. 79, 152160.
  • Halkitis P. N., Parsons J. T. and Stirratt M. J. (2001) A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J. Homosex. 41, 1735.
  • Hayman M., Arbuthnott G., Harkiss G., Brace H., Filippi P., Philippon V., Thomson D., Vigne R. and Wright A. (1993) Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience 53, 16.
  • Hirata H., Ladenheim B., Rothman R. B., Epstein C. and Cadet J. L. (1995) Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677, 345347.
  • Imam S. Z., El-Yazal J., Newport G. D., Itzhak Y., Cadet J. L., Slikker W. Jr and Ali S. F. (2001) Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann. N. Y. Acad. Sci. 939, 366380.
  • Kogan F. J., Nichols W. K. and Gibb J. W. (1976) Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 36, 363371.
  • Kolson D. L. and Pomerantz R. J. (1996) AIDS dementia and HIV-1-induced neurotoxicity: possible pathogenic associations and mechanisms. J. Biomed. Sci. 3, 389414.
  • Kruman I., Nath A. and Mattson M. P. (1998) HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp. Neurol. 154, 276288.
  • Kure K., Weidenheim K. M., Lyman W. D. and Dickson D. W. (1990) Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta. Neuropathol. (Berl.) 80, 393400.
  • Ladenheim B., Krasnova I. N., Deng X., Oyler J. M., Polettini A., Moran T. H., Huestis M. A. and CadetJ. L. (2000) Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol. Pharmacol. 58, 12471256.
  • Larsson M., Hagberg L., Forsman A. and Norkrans G. (1991) Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. J. Neurosci. Res. 28, 406409.
  • LaVoie M. J. and Hastings T. G. (1999) Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. J. Neurochem. 73, 25462554.
  • Lorez H. (1981) Fluorescence histochemistry indicates damage of striatal dopamine nerve terminals in rats after multiple doses of methamphetamine. Life Sci. 28, 911916.
  • Ma M. and Nath A. (1997) Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 71, 24952499.
  • Magnuson D. S., Knudsen B. E., Geiger J. D., Brownstone R. M. and Nath A. (1995) Human immunodeficiency virus type 1 tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37, 373380.
  • Maragos W. F., Jakel R., Chesnut D., Pocernich C. B., Butterfield D. A., St Clair D. and Cass W. A. (2000) Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Brain Res. 878, 218222.
  • McCann U. D., Wong D. F., Yokoi F., Villemagne V., Dannals R. F. and Ricaurte G. A. (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35, 428. J. Neurosci. 18, 84178422.
  • Miller M. and Hughes A. (1994) Epidemiology of Amphetamine Use in the United States. Academic Press, San Diego.
  • Mirsattari S. M., Power C. and Nath A. (1998) Parkinsonism with HIV infection. Mov. Disord. 13, 684689.
  • Molitor F., Truax S. R., Ruiz J. D. and Sun R. K. (1998) Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West. J. Med. 168, 9397.
  • Nakayama M., Koyama T. and Yamashita I. (1993) Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum. Brain Res. 601, 209212.
  • Nath A. and Geiger J. (1998) Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog. Neurobiol. 54, 1933.
  • Nath A., Psooy K., Martin C., Knudsen B., Magnuson D. S., Haughey N. and Geiger J. D. (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70, 14751480.
  • Nath A., Conant K., Chen P., Scott C. and Major E. O. (1999) Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J. Biol. Chem. 274, 1709817102.
  • Nath A., Maragos W. F., Avison M. J., Schmitt F. A. and Berger J. R. (2001) Acceleration of HIV dementia with methamphetamine and cocaine. J. Neurovirol. 7, 6671.
  • New D. R., Ma M., Epstein L. G., Nath A. and Gelbard H. A. (1997) Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol. 3, 168173.
  • O'Callaghan J. P. and Miller D. B. (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270, 741751.
  • Orth M. and Schapira A. H. (2001) Mitochondria and degenerative disorders. Am. J. Med. Genet. 106, 2736.
  • Philippon V., Vellutini C., Gambarelli D., Harkiss G., Arbuthnott G., Metzger D., Roubin R. and Filippi P. (1994) The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 205, 519529.
  • Pogun S., Baumann M. H. and Kuhar M. J. (1994) Nitric oxide inhibits [3H]dopamine uptake. Brain Res. 641, 8391.
  • Pu C., Fisher J. E., Cappon G. D. and Vorhees C. V. (1994) The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum. Brain Res. 649, 217224.
  • Reyes M. G., Faraldi F., Senseng C. S., Flowers C. and Fariello R. (1991) Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta. Neuropathol. (Berl.) 82, 3944.
  • Ricaurte G. A., Guillery R. W., Seiden L. S., Schuster C. R. and Moore R. Y. (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235, 93103.
  • Di Rocco A., Bottiglieri T., Dorfman D., Werner P., Morrison C. and Simpson D. (2000) Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients. Clin. Neuropharmacol. 23, 190194.
  • Rustin P. (2001) Mitochondrial dysfunction in HIV infection: an overview of pathogenesis. J. HIV Ther. 6, 412.
  • Sabatier J. M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B. and Bahraoui E. (1991) Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65, 961967.
  • Sardar A., Czudek C. and Reynolds G. P. (1996) Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 7, 910912.
  • Smiley S. T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T. W., Steele G. D. Jr and Chen L. B. (1991) Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl Acad. Sci. USA 88, 36713675.
  • Sonsalla P. K., Nicklas W. J. and Heikkila R. E. (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243, 398400.
  • Stadlin A., Lau J. W. and Szeto Y. K. (1998) A selective regional response of cultured astrocytes to methamphetamine. Ann. N. Y. Acad. Sci. 844, 108121.
  • Trulson M. E., Cannon M. S., Faegg T. S. and Raese J. D. (1985) Effects of chronic methamphetamine on the nigral–striatal dopamine system in rat brain: tyrosine hydroxylase immunochemistry and quantitative light microscopic studies. Brain Res. Bull. 15, 569577.
  • Turchan J., Anderson C., Hauser K. F., Sun Q., Zhang J., Liu Y., Wise P. M., Kruman I., Maragos W., Mattson M. P., Booze R. and Nath A. (2001) Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci. 2, 3.
  • Volkow N. D., Chang L., Wang G. J., Fowler J. S., Franceschi D., Sedler M., Gatley S. J., Miller E., Hitzemann R., Ding Y. S. and Logan J. (2001) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21, 94149418.
  • Wagner G. C., Ricaurte G. A., Seiden L. S., Schuster C. R., Miller R. J. and Westley J. (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181, 151160.
  • Wang P., Barks J. D. and Silverstein F. S. (1999) Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats. Neuroscience 88, 585597.
  • Wendel A., Kuesters S. and Tiegs G. (1997) Ebselen – an in vivo immune response modifier. Biomed Environ. Sci. 10, 253259.
  • Zauli G., Secchiero P., Rodella L., Gibellini D., Mirandola P., Mazzoni M., Milani D., Dowd D. R., Capitani S. and Vitale M. (2000) HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. J. Biol. Chem. 275, 41594165.
  • Zhang Y., Marcillat O., Giulivi C., Ernster L. and Davies K. J. (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265, 1633016336.